Matches in Wikidata for { <http://www.wikidata.org/entity/Q65359390> ?p ?o ?g. }
Showing items 1 to 59 of
59
with 100 items per page.
- Q65359390 description "clinical trial" @default.
- Q65359390 description "ensayu clínicu" @default.
- Q65359390 description "klinisch onderzoek" @default.
- Q65359390 description "клінічне випробування" @default.
- Q65359390 name "Efficacy of Dose Intensification in Patients With Non-metastatic Ewing Sarcoma" @default.
- Q65359390 name "Efficacy of Dose Intensification in Patients With Non-metastatic Ewing Sarcoma" @default.
- Q65359390 type Item @default.
- Q65359390 label "Efficacy of Dose Intensification in Patients With Non-metastatic Ewing Sarcoma" @default.
- Q65359390 label "Efficacy of Dose Intensification in Patients With Non-metastatic Ewing Sarcoma" @default.
- Q65359390 prefLabel "Efficacy of Dose Intensification in Patients With Non-metastatic Ewing Sarcoma" @default.
- Q65359390 prefLabel "Efficacy of Dose Intensification in Patients With Non-metastatic Ewing Sarcoma" @default.
- Q65359390 P1050 Q65359390-AFAC9BFA-C8D5-4AF8-B926-D0877CC691FC @default.
- Q65359390 P1132 Q65359390-43352A5B-C275-43D2-8937-7FB2F6B0CF4A @default.
- Q65359390 P1476 Q65359390-5938EFC2-531B-46B7-BFA6-1106E56752F6 @default.
- Q65359390 P17 Q65359390-2F2EC4DF-C3D9-4E84-A9FE-CA09A3FF9D10 @default.
- Q65359390 P1813 Q65359390-3B6D8AE9-4F87-41F1-B869-5C170B25E8BB @default.
- Q65359390 P3098 Q65359390-24B16B0C-677D-42C3-A280-BB78E392DC6D @default.
- Q65359390 P31 Q65359390-1844BEE1-08EF-46DB-ABCE-EE1612C2B8E0 @default.
- Q65359390 P4135 Q65359390-D535C9EF-0462-4D7B-AF8C-251394AAD149 @default.
- Q65359390 P4844 Q65359390-4B939F64-5A3C-4D4D-ACF8-F431CD102021 @default.
- Q65359390 P4844 Q65359390-6A3535C1-30C9-4310-86F6-9485DCE44C3C @default.
- Q65359390 P4844 Q65359390-6FE27331-232A-4CBA-A6B9-456CB27F78D1 @default.
- Q65359390 P4844 Q65359390-7EC33BAB-314D-4028-A031-EBC1FA1D947E @default.
- Q65359390 P4844 Q65359390-944D0311-2700-438E-B537-FAECB59854A6 @default.
- Q65359390 P4844 Q65359390-AFFAB35B-B69F-4613-99F2-82BD071EAAD6 @default.
- Q65359390 P4844 Q65359390-B0DC1275-92D9-40F5-BF49-F0122B11218D @default.
- Q65359390 P580 Q65359390-B99C9F02-F14A-481E-9759-AAF6F1B24E4F @default.
- Q65359390 P582 Q65359390-7A585C96-D93C-49DA-8352-80DCBDE4FAAD @default.
- Q65359390 P6099 Q65359390-794CB3E7-B1BC-43BD-933C-5ACD96AACAD4 @default.
- Q65359390 P6153 Q65359390-381D0743-EFB9-4B7A-AFEA-BD8A840BBAB1 @default.
- Q65359390 P6153 Q65359390-C9F1D5FB-2AF3-48BA-87B8-A63C1FE837D3 @default.
- Q65359390 P6153 Q65359390-D0B42179-B0F1-4A60-B5CC-DD458DDFAEDB @default.
- Q65359390 P6153 Q65359390-F62DBDDB-088D-41B8-85C9-6A31F83F3ACC @default.
- Q65359390 P8363 Q65359390-F429DAC2-B952-4D7D-9452-0FBC5C686C7A @default.
- Q65359390 P859 Q65359390-010B287A-6695-4DAF-AF99-414C49A372DF @default.
- Q65359390 P1050 Q223911 @default.
- Q65359390 P1132 "+242" @default.
- Q65359390 P1476 "Phase III Study on Efficacy of Dose Intensification in Patients With Non-metastatic Ewing Sarcoma." @default.
- Q65359390 P17 Q38 @default.
- Q65359390 P1813 "EW-1" @default.
- Q65359390 P3098 "NCT02063022" @default.
- Q65359390 P31 Q30612 @default.
- Q65359390 P4135 "+40" @default.
- Q65359390 P4844 Q186127 @default.
- Q65359390 P4844 Q18936 @default.
- Q65359390 P4844 Q2298283 @default.
- Q65359390 P4844 Q27260984 @default.
- Q65359390 P4844 Q29004943 @default.
- Q65359390 P4844 Q408524 @default.
- Q65359390 P4844 Q418560 @default.
- Q65359390 P580 "2009-01-22T00:00:00Z" @default.
- Q65359390 P582 "2021-12-20T00:00:00Z" @default.
- Q65359390 P6099 Q42824827 @default.
- Q65359390 P6153 Q204441 @default.
- Q65359390 P6153 Q30253940 @default.
- Q65359390 P6153 Q30279623 @default.
- Q65359390 P6153 Q3803656 @default.
- Q65359390 P8363 Q78089383 @default.
- Q65359390 P859 Q30269055 @default.